Clinical Report: Mid-Esophageal Mucosal Impedance and Refractory Reflux Symptoms

Overview

Revise to include specific findings and their implications for treatment strategies.

Background

Refractory reflux-like symptoms are prevalent and pose significant management challenges for clinicians, with many patients showing persistent symptoms despite proton pump inhibitor therapy. Accurate assessment of esophageal mucosal integrity is crucial for understanding the etiology of these symptoms. The Lyon Consensus advocates for the use of esophageal mucosal impedance as a diagnostic tool to evaluate mucosal barrier function and inflammation, which may enhance treatment outcomes.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Mid-esophageal mucosal impedance can reflect broader mucosal integrity independent of acute acid injury.
• Baseline impedance (BI) and mean nocturnal baseline impedance (MNBI) are effective metrics for assessing mucosal integrity.
• Patients with rRLS often show no objective evidence of GERD despite persistent symptoms.
• Impedance measurements may help differentiate between various phenotypes of reflux-like symptoms.
• Objective assessment of mucosal integrity can influence treatment strategies for patients with rRLS.

Clinical Implications

Clinicians should consider mid-esophageal mucosal impedance measurements in patients with refractory reflux-like symptoms to better understand the underlying causes and tailor treatment approaches. This objective assessment may lead to improved management and outcomes for patients who do not respond to standard therapies.

Conclusion

Mid-esophageal mucosal impedance serves as a promising tool for evaluating mucosal integrity in patients with refractory reflux-like symptoms, potentially guiding more effective treatment strategies. Further research is warranted to establish standardized protocols for its clinical application.

References

1. Updates in Surgery, 2022 -- Evaluating Nocturnal Baseline Impedance and Endoscopic Mucosal Impedance in Eosinophilic Esophagitis Patients: A Novel Approach for Monitoring and Treatment?
2. Journal of Gastroenterology, 2012 -- Baseline Impedance Measurements in the Esophagus Correlate with Acid Reflux Severity and Epithelial Changes in Gastroesophageal Reflux Disease Patients
3. the new gastroenterologist, 2025 -- Approach to dysphagia
4. Journal of Gastroenterology, 2019 -- Impaired Mucosal Integrity in the Duodenum and Jejunum of Dyspeptic Patients: An In Vivo Evaluation of Small Bowel Mucosal Integrity via Baseline Impedance
5. Updates to the modern diagnosis of GERD: Lyon consensus 2.0 | Gut
6. Mid-esophageal mucosal impedance reflects mucosal integrity and phenotypes refractory reflux-like symptoms - PMC
7. Updates to the modern diagnosis of GERD: Lyon consensus 2.0 | Gut
8. Mid-esophageal mucosal impedance reflects mucosal integrity and phenotypes refractory reflux-like symptoms - PMC
9. AGA Issues Guidance on Using P-CABs